SKLB 610

DESCRIPTION

SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, at the concentration of 10 μM in biochemical kinase assays.

DETAILS

Cas: 1125780-41-7
Purity: 99.30%
Smiles: O(C=1C=C(C(NC)=O)N=CC1)C2=CC=C(NC(=O)C3=CC(C(F)(F)F)=CC=C3)C=C2
Category: Compound
Molecular Weight: 415.37
Molecular Formula: C21H16F3N3O3

Lead Time: 4 - 5 weeks